Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Burden

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Investigative Dermatology|June 9, 2015
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Richard B Warren, Catherine H Smith, Zenas Z N Yiu, et al.
The New England Journal of Medicine|December 22, 2021
Trial of Spesolimab for Generalized Pustular PsoriasisHervé Bachelez, Siew-Eng Choon, Slaheddine Marrakchi, et al.
The Journal of Investigative Dermatology|April 18, 2016
Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-AnalysisZenas Z N Yiu, Lesley S Exton, Zarif Jabbar-Lopez, et al.
The Journal of Investigative Dermatology|December 21, 2020
Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis-CorrectionCatherine H Smith, Satveer K Mahil, Zenas Z N Yiu, et al.
The Journal of Investigative Dermatology|March 22, 2003
Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosisKati Asumalahti, Mahreen Ameen, Sari Suomela, et al.
The Journal of Investigative Dermatology|January 11, 2013
Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypesNiovi Setta-Kaffetzi, Alexander A Navarini, Varsha M Patel, et al.
The Journal of Investigative Dermatology|April 14, 2020
Clinical Impact of Antibodies against Ustekinumab in Psoriasis: An Observational, Cross-Sectional, Multicenter StudyFloris C Loeff, Teresa Tsakok, Lisanne Dijk, et al.
The Journal of Allergy and Clinical Immunology|May 14, 2022
Single-cell analysis implicates T<sub>H</sub>17-to-T<sub>H</sub>2 cell plasticity in the pathogenesis of palmoplantar pustulosisDaniel McCluskey, Natashia Benzian-Olsson, Satveer K Mahil, et al.
Human Molecular Genetics|March 28, 2008
Identification of ZNF313/RNF114 as a novel psoriasis susceptibility geneFrancesca Capon, Marie-José Bijlmakers, Natalie Wolf, et al.
The Journal of Investigative Dermatology|July 24, 2015
Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis VulgarisDorottya M Berki, Lu Liu, Siew-Eng Choon, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Investigative Dermatology|June 9, 2015
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Richard B Warren, Catherine H Smith, Zenas Z N Yiu, et al.
The New England Journal of Medicine|December 22, 2021
Trial of Spesolimab for Generalized Pustular PsoriasisHervé Bachelez, Siew-Eng Choon, Slaheddine Marrakchi, et al.
The Journal of Investigative Dermatology|April 18, 2016
Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-AnalysisZenas Z N Yiu, Lesley S Exton, Zarif Jabbar-Lopez, et al.
The Journal of Investigative Dermatology|December 21, 2020
Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis-CorrectionCatherine H Smith, Satveer K Mahil, Zenas Z N Yiu, et al.
The Journal of Investigative Dermatology|March 22, 2003
Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosisKati Asumalahti, Mahreen Ameen, Sari Suomela, et al.
The Journal of Investigative Dermatology|January 11, 2013
Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypesNiovi Setta-Kaffetzi, Alexander A Navarini, Varsha M Patel, et al.
The Journal of Investigative Dermatology|April 14, 2020
Clinical Impact of Antibodies against Ustekinumab in Psoriasis: An Observational, Cross-Sectional, Multicenter StudyFloris C Loeff, Teresa Tsakok, Lisanne Dijk, et al.
The Journal of Allergy and Clinical Immunology|May 14, 2022
Single-cell analysis implicates T<sub>H</sub>17-to-T<sub>H</sub>2 cell plasticity in the pathogenesis of palmoplantar pustulosisDaniel McCluskey, Natashia Benzian-Olsson, Satveer K Mahil, et al.
Human Molecular Genetics|March 28, 2008
Identification of ZNF313/RNF114 as a novel psoriasis susceptibility geneFrancesca Capon, Marie-José Bijlmakers, Natalie Wolf, et al.
The Journal of Investigative Dermatology|July 24, 2015
Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis VulgarisDorottya M Berki, Lu Liu, Siew-Eng Choon, et al.
Pageof 9